Zurcher Kantonalbank (Zurich Cantonalbank) - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 157 filers reported holding SERES THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$72,811
-50.3%
30,5930.0%0.00%
-100.0%
Q2 2023$146,540
+7.6%
30,593
+27.4%
0.00%0.0%
Q1 2023$136,137
+40.7%
24,010
+39.0%
0.00%0.0%
Q4 2022$96,746
+42.3%
17,276
+61.9%
0.00%
Q3 2022$68,000
+83.8%
10,6680.0%0.00%
Q2 2022$37,000
-51.3%
10,6680.0%0.00%
Q1 2022$76,000
+33.3%
10,668
+54.8%
0.00%
Q4 2021$57,000
+18.8%
6,8930.0%0.00%
Q3 2021$48,000
-70.7%
6,8930.0%0.00%
-100.0%
Q2 2021$164,000
-7.9%
6,893
-20.3%
0.00%0.0%
Q1 2021$178,000
-16.0%
8,6500.0%0.00%0.0%
Q4 2020$212,000
+2928.6%
8,650
+699.4%
0.00%
Q1 2019$7,000
+40.0%
1,0820.0%0.00%
Q4 2018$5,000
-37.5%
1,0820.0%0.00%
Q3 2018$8,000
-11.1%
1,0820.0%0.00%
Q2 2018$9,000
+12.5%
1,0820.0%0.00%
Q1 2018$8,000
-27.3%
1,0820.0%0.00%
Q4 2017$11,000
-35.3%
1,0820.0%0.00%
Q3 2017$17,000
+41.7%
1,0820.0%0.00%
Q2 2017$12,0000.0%1,0820.0%0.00%
Q1 2017$12,000
+9.1%
1,0820.0%0.00%
Q4 2016$11,0001,0820.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$110,730,6464.94%
Lion Point Capital, LP 691,803$3,313,7361.50%
Eversept Partners, LP 3,076,756$14,737,6611.23%
Soleus Capital Management, L.P. 2,045,983$9,800,2591.09%
Knott David M Jr 470,000$2,2510.90%
GREAT POINT PARTNERS LLC 938,067$4,493,3410.88%
Simplify Asset Management Inc. 550,626$2,637,4990.35%
Delphia (USA) Inc. 33,913$162,4430.26%
Alpha DNA Investment Management LLC 138,536$663,5870.22%
Avoro Capital Advisors LLC 2,500,000$11,975,0000.16%
View complete list of SERES THERAPEUTICS INC shareholders